Back to RARE
B Group, Inc. RARE Position History
Ultragenyx Pharmaceutical Inc. • Healthcare
Quarters held
4
Latest value
$2M
Q3 2026
Peak value
$4.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $3.1M |
| Q1 2026 | $2.8M |
| Q2 2026 | $4.5M |
| Q3 2026 | $2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2M | 135.0K | — | — |
| Q2 2026 | $4.5M | 135.0K | — | — |
| Q1 2026 | $2.8M | 135.0K | — | — |
| Q4 2025 | $3.1M | 135.0K | — | — |
Other funds holding RARE
$365.5M
$356.7M
$283.9M
$260.3M
$219.1M
$213.3M
$205.6M